Company
Headquarters: Paris, France
Employees: 47
CEO: Mr. Michel Finance
€53.3 Million
EUR as of July 1, 2025
US$63.0 Million
Company | Market Cap (USD) |
---|---|
Abbott | $233.33 B |
Boston Scientific Corporation | $154.34 B |
Stryker | $151.06 B |
Medtronic | $113.25 B |
Edwards Lifesciences Corporation | $45.05 B |
Company | Market Cap (USD) |
---|---|
Lilly | $699.59 B |
Johnson & Johnson | $374.29 B |
AbbVie | $336.94 B |
Novo Nordisk | $309.91 B |
UnitedHealth Group | $279.90 B |
Affluent Medical SA, a medical devices company, designs, develops, manufactures, and markets implantable prostheses devices in France. The company develops Kardiozis prosthesis for the noninvasive treatment of abdominal aortic aneurysm; Kalios and Epygon implants for the treatment of mitral insufficiency; and Artus implant, an artificial electromechanical implantable sphincter for severe urinary incontinence in women and men. The company was founded in 2011 and is headquartered in Aix-en-Provence, France.
Affluent Medical SA has the following listings and related stock indices.
Stock: Euronext: AFME wb_incandescent
Stock: FSX: 0JZ wb_incandescent